Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Werewolf Therapeutics (HOWL) Current Assets (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Current Assets for 5 consecutive years, with $68.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Current Assets fell 45.82% to $68.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $68.2 million, a 45.82% decrease, with the full-year FY2024 number at $113.1 million, down 18.29% from a year prior.
  • Current Assets was $68.2 million for Q3 2025 at Werewolf Therapeutics, down from $80.4 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $186.4 million in Q2 2021 to a low of $68.2 million in Q3 2025.
  • A 5-year average of $133.8 million and a median of $140.2 million in 2022 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: soared 71.37% in 2022, then tumbled 45.82% in 2025.
  • Werewolf Therapeutics' Current Assets stood at $161.1 million in 2021, then dropped by 12.96% to $140.2 million in 2022, then fell by 1.31% to $138.4 million in 2023, then decreased by 18.29% to $113.1 million in 2024, then tumbled by 39.71% to $68.2 million in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Current Assets are $68.2 million (Q3 2025), $80.4 million (Q2 2025), and $94.5 million (Q1 2025).